Maker of iconic brands such as Neutrogena®, Listerine®, Aveeno® and Tylenol® aims to advance the well-being of people and planet through its
SBTi has validated Kenvue's near-term targets as in-line with the urgent actions needed to limit the global temperature rise to 1.5°C:
- Kenvue commits to reduce absolute Scope 1 and 2 GHG emissions1,2,3 42% by 20304 from a 2020 base year
- Kenvue also commits that 75% of its suppliers by emissions covering purchased goods and services and upstream transportation and distribution will have science-based targets by 2028.4
"We recognize the increasingly detrimental impact climate change is having on people and ecosystems around the world. As a company dedicated to a healthy future, we are setting ambitious science-based emissions reduction targets and action plans to decarbonize our products, operations, and value chain," said Pamela Gill-Alabaster*, Global Head of ESG & Sustainability at Kenvue. "We are proud that the SBTi has validated our climate targets so early in our new company's journey, and this important milestone signals our intent to create a positive change and make meaningful progress in support of our
These validated near-term targets and the Kenvue commitment to set long-term net zero emissions targets informed by the SBTi Net Zero Standard support
About Kenvue
Kenvue is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand Adhesive Bandages, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
Investor Relations:
Kenvue_IR@kenvue.com
Media Relations:
media@kenvue.com
* Pamela Gill-Alabaster is an employee of
Cautions Concerning Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding the Company's climate goals and its
A list and descriptions of risks, uncertainties and other factors can be found in Kenvue's filings with the
1 Applies to all Kenvue-owned facilities where Kenvue has operational control, regardless of building type; all leased facilities used for manufacturing and/or research & development; and leased, non-manufacturing and/or non-research & development facilities where the facility is greater than 50,000 square feet and where Kenvue has operational control. The 2020 baseline includes all facilities aligned to Kenvue's structure upon separation from
2The target boundary includes land-related emissions and removals from bioenergy feedstocks.
3 The inventory was compiled in accordance with the
4 We aim to meet the goal by end of fiscal year and publish the year after.
.
(C) 2024 M2 COMMUNICATIONS, source